Pointe 360
Hexokinase, Glucose. 510(k) K062118, from Pointe Scientific, Inc., (Lincoln Park, MI). Product code CFR, class 2.
As of Nov 19, 2026, K062118 is an FDA 510(k) held by Pointe Scientific, Inc.,, substantially equivalent on Jul 13, 2007 after 353 days, with no recalls tied to it in FDA's recall database.
- Review time: 353 days
- Recalls: 0
k062118 Glucose Hexokinase Reagent The Glucose Hexokinase reagent set is intended to be used in a diagnostic laboratory setting by qualified laboratory technologists for the quantitative determination of glucose in human serum and plasma on the Pointe 360 Analyzer. It is for In Vitro diagnostic use only.
- Roche Reagent for GlucoseK953847 · Roche Diagnostic Systems, Inc. · Feb 13, 1996
- Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsK253490 · Roche Diagnostics · Feb 12, 2026
- Glucose2K252357 · Abbott Ireland · Oct 24, 2025
- cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSHK220134 · Roche Diagnostics · Sep 16, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 25, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files